Bod Australia Ltd (ASX:BDA) has imported Swiss herbal extracts company Linnea SA's proprietary cannabidiol (CBD) extract powder, ECs315, for use in its upcoming phase I clinical trial. The powder will be incorporated into a proprietary sublingual wafer delivery solution (WaferiX®) developed through ...
read more here
Delivered by @can_nab_is
No comments:
Post a Comment